About: Pierre Kory

An Entity of Type: medician, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC). Kory testified twice to the U.S. Senate regarding COVID-19. During his testimony in December 2020, Kory erroneously claimed that the antiparasitic medication ivermectin was a "wonder drug" with "miraculous effectiveness" against COVID-19.

Property Value
dbo:abstract
  • Pierre Kory est un médecin américain spécialisé dans les soins intensifs. Il a attiré l'attention lors de la pandémie de Covid-19 en préconisant l'utilisation généralisée, hors AMM, de certains médicaments comme traitements contre la Covid-19, en tant que président et cofondateur de la Front Line COVID-19 Critical Care Alliance (FLCCC).Il a témoigné deux fois au Sénat américain concernant le Covid-19. Lors de son témoignage en décembre 2020, Kory a affirmé que le médicament antiparasitaire ivermectine était un « médicament miracle » avec une « efficacité miraculeuse » contre le Covid-19. (fr)
  • Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC). Kory testified twice to the U.S. Senate regarding COVID-19. During his testimony in December 2020, Kory erroneously claimed that the antiparasitic medication ivermectin was a "wonder drug" with "miraculous effectiveness" against COVID-19. (en)
  • ピエール・コリーは、COVID-19のパンデミックの際に、COVID-19の治療法として特定の薬剤の適応外使用を広めることを提唱したことで注目を集めたアメリカの救命救急医である。 コリーはCOVID-19に関して米国議会上院の前で2回証言した。 2020年12月の証言の中で、コリーは、駆虫薬のイベルメクチンがCOVID-19に対して「奇跡的な効果」を持つ「不思議な薬」であると主張した 。 (ja)
dbo:institution
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 66533988 (xsd:integer)
dbo:wikiPageLength
  • 20714 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1121884347 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
dbp:caption
  • Kory in front of the US Senate in 2020 (en)
dbp:field
dbp:knownFor
  • COVID-19 misinformation (en)
dbp:name
  • Pierre Kory (en)
dbp:wikiPageUsesTemplate
dbp:workInstitutions
dcterms:subject
rdf:type
rdfs:comment
  • Pierre Kory est un médecin américain spécialisé dans les soins intensifs. Il a attiré l'attention lors de la pandémie de Covid-19 en préconisant l'utilisation généralisée, hors AMM, de certains médicaments comme traitements contre la Covid-19, en tant que président et cofondateur de la Front Line COVID-19 Critical Care Alliance (FLCCC).Il a témoigné deux fois au Sénat américain concernant le Covid-19. Lors de son témoignage en décembre 2020, Kory a affirmé que le médicament antiparasitaire ivermectine était un « médicament miracle » avec une « efficacité miraculeuse » contre le Covid-19. (fr)
  • Pierre Kory is an American critical care physician who gained attention during the COVID-19 pandemic for advocating widespread off-label use of certain drugs as treatments for COVID-19, as president and co-founder of the Front Line COVID-19 Critical Care Alliance (FLCCC). Kory testified twice to the U.S. Senate regarding COVID-19. During his testimony in December 2020, Kory erroneously claimed that the antiparasitic medication ivermectin was a "wonder drug" with "miraculous effectiveness" against COVID-19. (en)
  • ピエール・コリーは、COVID-19のパンデミックの際に、COVID-19の治療法として特定の薬剤の適応外使用を広めることを提唱したことで注目を集めたアメリカの救命救急医である。 コリーはCOVID-19に関して米国議会上院の前で2回証言した。 2020年12月の証言の中で、コリーは、駆虫薬のイベルメクチンがCOVID-19に対して「奇跡的な効果」を持つ「不思議な薬」であると主張した 。 (ja)
rdfs:label
  • Pierre Kory (fr)
  • ピエール・コリー (ja)
  • Pierre Kory (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Pierre Kory (en)
is dbo:person of
is dbo:wikiPageDisambiguates of
is dbo:wikiPageWikiLink of
is dbp:leaderName of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License